# Switching Undetectables to Selzentry

> **NCT01866267** · PHASE4 · COMPLETED · sponsor: **St. Hope Foundation** · enrollment: 31 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- AIDS

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT01866267
- **Lead sponsor:** St. Hope Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2014-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01866267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01866267, "Switching Undetectables to Selzentry". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01866267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*